Loading...
VSTA is not a good buy right now. With no Intellectia buy signals, weakening momentum (bearish MACD expansion), and a statistically negative 1-month pattern outlook (-6.68%), the near-term setup does not favor an impatient buyer. I would avoid new entries here and would sell/step aside until price reclaims key resistance levels and momentum turns up.
Trend/momentum is currently bearish to neutral. MACD histogram is below zero (-0.015) and negatively expanding, indicating downside momentum is building rather than stabilizing. RSI(6) at ~38.4 is weak (near, but not clearly at, oversold), suggesting sellers still have control. Moving averages are converging, which often precedes a larger move; given the negative MACD, the bias is down. Key levels: immediate support S1=4.678 (then S2=4.577). If 4.678 breaks, downside risk increases quickly toward 4.58. Resistance sits near Pivot=4.842, then R1=5.007; price needs to regain and hold above ~4.84–5.01 to improve the short-term technical picture. Pattern-based projection: ~90% chance of -0.41% next day, +1.38% next week, and -6.68% next month—overall unfavorable for a buy-now decision.
Gross margin improved materially in 2025/Q3 (67.92%, +7.59% YoY), and revenue grew +13.36% YoY—signals of operational strength on the top line and profitability at the gross level. A bounce could occur if support at ~4.68 holds and price reclaims ~4.84–5.01 quickly.
Profitability is deteriorating: 2025/Q3 net income fell to -59.77M (more negative, -22.52% YoY) and EPS declined to -0.74 (-19.57% YoY). Technical momentum is weakening (MACD negative and expanding) and the 1-month statistical outlook is negative (-6.68%). No news catalysts in the past week to reverse sentiment. Hedge fund and insider trading trends are neutral, offering no supportive flow signal.
Latest reported quarter: 2025/Q3. Revenue increased to 249.602M (+13.36% YoY), indicating continued top-line growth. However, net income worsened to -59.77M (-22.52% YoY) and EPS declined to -0.74 (-19.57% YoY), meaning losses deepened despite stronger revenue. Gross margin rose to 67.92% (+7.59% YoY), which is a positive efficiency indicator, but it has not translated into bottom-line improvement yet.
No analyst rating or price-target trend data was provided, so recent Wall Street upgrades/downgrades and the bull/bear consensus cannot be assessed from the dataset.